NSERumour Verification - Regulation 30(11)10 Sept 2026 · 10 Sept 2026, 05:11 pm
Rumour Verification - Regulation 30(11)
Eris Lifesciences Limited · ERIS
✦ AI SummaryRegulatory
Eris Lifesciences Limited has clarified a news article regarding a loan disclosure, stating that the correct value of the loan is as previously disclosed by the company.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Eris Lifesciences Limited has informed the Exchange about Rumour Verification - Regulation 30(11)
Attachments (1)
📄pdf
Download →
ERIS_10092026171134_Intimationsigned.pdf
View document text
Date: 10 September 2026
To To
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza
Dalal Street Bandra Kurla Complex
Mumbai- 400001 Bandra (E)
Mumbai-400051
Security Code: 540596 Symbol: ERIS
SUBJECT: CLARIFICATION ON NEWS ARTICLE PURSUANT TO REGULATION 30 OF THE SEBI (LODR)
REGULATIONS, 2015
We refer to the publications InvestyWise News, dealroom.co and possibly others covering the disclosure of the
company dated 9th September 2026.
It may be noted that the correct value of loan availed by the company is what appears in the disclosure already
made by the company (see here).
Readers would be well advised to refer and rely on the exchange disseminated information by the company
before taking any investment related decisions pertaining to the securities of the company.
For Eris Lifesciences Limited
Milind Talegaonkar
Company Secretary & Compliance Officer
Membership No: A26493